Project Number AFTD-Finkbeiner-2017 Agency/Funding Organization The Association for Frontotemporal Degeneration Funding Year 2017 View Full Project Details for Novel human FTLD neuron and microglia cell models for drug discovery Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies c. C9ORF-72 and Progranulin Category F. Research Resources 6. Disease Models e. iPS Cells Researcher and Organization Principal Investigator Finkbeiner, Steven Principal Investigator First Name Steven Principal Investigator Last Name Finkbeiner Awardee Organization The J. David Gladstone Institutes Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement Accelerating Drug Discovery for Frontotemporal Degeneration 2017 RFP FY Overall Cost $150,000 Funding Organization Agency/Funding Organization The Association for Frontotemporal Degeneration Funding Organization Country United States Program Official Nadine Tatton (AFTD)/Lauren Friedman (ADDF) Special Initiative Accelerating Drug Discovery for Frontotemporal Degeneration - AFTD Accelerating Drug Discovery for Frontotemporal Dementia - ADDF